These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6109633)

  • 1. Binding of perazine to alpha 1-acid glycoprotein.
    Schley J; Siegert M; Müller-Oerlinghausen B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):501-4. PubMed ID: 6109633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of phenothiazines on the binding of [3H]perazine to alpha 1-acid glycoprotein.
    Schley J
    J Pharm Pharmacol; 1987 Feb; 39(2):132-4. PubMed ID: 2881999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of alpha 1-acid glycoprotein, lipoproteins, and albumin to the plasma binding of perazine, amitriptyline, and nortriptyline in healthy man.
    Brinkschulte M; Breyer-Pfaff U
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):61-6. PubMed ID: 6108517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Binding of perazine metabolites and phenothiazine derivatives to acid alpha 1-glycoprotein].
    Schley J
    Arzneimittelforschung; 1983; 33(2):185-7. PubMed ID: 6133521
    [No Abstract]   [Full Text] [Related]  

  • 5. High affinity binding of perazine and desmethylperazine to human alpha 1-acid glycoprotein.
    Schley J; Nündel M; Siegert M; Riedel E; Müller-Oerlinghausen B
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):144-5. PubMed ID: 6104826
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma protein binding of perazine and amitriptyline in psychiatric patients.
    Brinkschulte M; Gaertner HJ; Schied HW; Breyer-Pfaff U
    Eur J Clin Pharmacol; 1982; 22(4):367-73. PubMed ID: 6125396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia.
    Gaebel W; Müller-Oerlinghausen B; Schley J
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):891-900. PubMed ID: 1355303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of amitriptyline and imipramine on the pharmacokinetics and metabolism of perazine in rats.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2000 Dec; 52(12):1473-81. PubMed ID: 11197075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific binding of perazine, a piperazine side-chain phenothiazine drug, to a serum protein (author's transl)].
    Schley J; Nündel M; Riedel E; Müller-Oerlinghausen B
    Arzneimittelforschung; 1979; 29(1):106-8. PubMed ID: 36101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism and excretion of the neuroleptic drug perazine in healthy volunteers].
    Schley J; Riedel E; Müller-Oerlinghausen B
    Int Pharmacopsychiatry; 1981; 16(4):201-11. PubMed ID: 6121765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine.
    Gaebel W; Pietzcker A; Ulrich G; Schley J; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1988 Nov; 21(6):384-6. PubMed ID: 2907645
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of chemically different psychotropic drugs to alpha 1-acid glycoprotein.
    Schley J; Müller-Oerlinghausen B
    Pharmacopsychiatria; 1983 May; 16(3):82-5. PubMed ID: 6611652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)].
    Pietzcker A; Müller-Oerlinghausen B; Schley J; Chaskel H; Poppenberg A; Urban R
    Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data.
    Breyer-Pfaff U; Brinkschulte M; Rein W; Schied HW; Straube E
    Pharmacopsychiatria; 1983 Sep; 16(5):160-5. PubMed ID: 6140695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients.
    Pietzcker A; Poppenberg A; Schley J; Müller-Oerlinghausen B
    Arch Psychiatr Nervenkr (1970); 1981; 229(4):315-29. PubMed ID: 6111989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of several phenothiazine neuroleptics to a common binding site of alpha 1-acid glycoprotein, orosomucoid.
    El-Gamal S; Wollert U; Müller WE
    J Pharm Sci; 1983 Feb; 72(2):202-5. PubMed ID: 6131996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of serum bioactivity levels of perazine and its metabolites by radioreceptor assay.
    Rao ML
    Pharmacopsychiatry; 1989 May; 22(3):104-7. PubMed ID: 2568642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.